Biomarkers: old–new, cardiac–noncardiac, all paving the way for better stratification in heart failure
Lipoprotein(a) should be taken much more seriously
Biomarkers of risk stratification in congestive heart failure: North American view
Novel biomarkers in heart failure: an overview
Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide
Prognostic utility of cardiac troponin in heart failure: a novel role for an established biomarker
ST2 protein in heart disease: from discovery to mechanisms and prognostic value
Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure
G-protein-coupled receptor kinases in cardiovascular conditions: focus on G-protein-coupled receptor kinase 2, a gain in translational medicine
Use of B-type natriuretic peptide in critically ill patients
Cardiorenal syndrome: biomarkers linking kidney damage with heart failure
Biomarkers may help predict risk of Alzheimer‘s disease
Novel biomarker predicts response to hepatitis C treatment
Potential novel fecal biomarkers for detecting gastrointestinal cancers
Prion identified as a biomarker for pancreatic cancer
Institutional Profile: The Emory Biomarker Service Center
Conference Scene: DGVS Spring Conference 2009
Identification of a β-casein-like peptide in breast nipple aspirate fluid that is associated with breast cancer
Endosialin: from vascular target to biomarker for human sarcomas
Genomic and metabolomic advances in the identification of disease and adverse event biomarkers
Smoking and atherosclerotic cardiovascular disease: Part II: Role of cigarette smoking in cardiovascular disease development
Acknowledgements